Pharming Group (PHAR)
10.41
+0.64
(+6.55%)
USD |
NASDAQ |
May 01, 16:00
10.41
0.00 (0.00%)
After-Hours: 20:00
Pharming Group Cash from Operations (TTM): -17.30M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -17.30M |
September 30, 2023 | -23.64M |
June 30, 2023 | -14.56M |
March 31, 2023 | -0.936M |
December 31, 2022 | 22.46M |
September 30, 2022 | 33.16M |
June 30, 2022 | 26.03M |
March 31, 2022 | 31.39M |
December 31, 2021 | 37.84M |
September 30, 2021 | 40.58M |
June 30, 2021 | 54.34M |
March 31, 2021 | 68.95M |
December 31, 2020 | 83.63M |
September 30, 2020 | 87.41M |
June 30, 2020 | 91.94M |
March 31, 2020 | 84.87M |
December 31, 2019 | 74.15M |
September 30, 2019 | 67.79M |
June 30, 2019 | 63.19M |
March 31, 2019 | 58.54M |
December 31, 2018 | 46.34M |
September 30, 2018 | 64.43M |
June 30, 2018 | 61.70M |
March 31, 2018 | 49.92M |
Date | Value |
---|---|
December 31, 2017 | 45.84M |
September 30, 2017 | 14.61M |
June 30, 2017 | -5.759M |
March 31, 2017 | -12.46M |
December 31, 2016 | -10.52M |
September 30, 2016 | -17.01M |
June 30, 2016 | -17.80M |
March 31, 2016 | -17.20M |
December 31, 2015 | -18.70M |
September 30, 2015 | -0.9328M |
June 30, 2015 | 1.438M |
March 31, 2015 | -1.684M |
December 31, 2014 | -3.129M |
September 30, 2014 | -7.763M |
June 30, 2014 | -5.322M |
March 31, 2014 | -2.733M |
December 31, 2013 | 0.00 |
September 30, 2013 | -8.226M |
June 30, 2013 | -12.92M |
March 31, 2013 | -12.49M |
December 31, 2012 | -13.58M |
September 30, 2012 | -33.62M |
June 30, 2012 | -32.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-23.64M
Minimum
Sep 2023
91.94M
Maximum
Jun 2020
42.70M
Average
40.58M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
uniQure NV | -145.93M |
ProQR Therapeutics NV | 23.33M |
Merus NV | -142.21M |
argenx SE | -- |
Pharvaris NV | -100.74M |